您当前所在的位置:首页 > 产品中心 > 产品详细信息
54-36-4 分子结构
点击图片或这里关闭

2-methyl-1,2-bis(pyridin-3-yl)propan-1-one

ChemBase编号:884
分子式:C14H14N2O
平均质量:226.27376
单一同位素质量:226.11061308
SMILES和InChIs

SMILES:
O=C(C(c1cccnc1)(C)C)c1cccnc1
Canonical SMILES:
O=C(C(c1cccnc1)(C)C)c1cccnc1
InChI:
InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3
InChIKey:
FJLBFSROUSIWMA-UHFFFAOYSA-N

引用这个纪录

CBID:884 http://www.chembase.cn/molecule-884.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
2-methyl-1,2-bis(pyridin-3-yl)propan-1-one
IUPAC传统名
metyrapone
商标名
Metapirone
Metapyron
Metapyrone
Metopiron
Metopyrone
Metopirone
别名
2-甲基-1,2-二-3-吡啶基-1-丙酮
美替拉酮
2-甲基-1,2-二-3-吡啶基-1-丙酮
2-Methyl-1,2-di-3-pyridyl-1-propanone
Metyrapone
Su-4885
Metyrapone
2-Methyl-1,2-di-3-pyridyl-1-propanone
Methapyrapone
Mepyrapone
Methbipyranone
Methopirapone
Methopyrapone
Methopyrinine
Methopyrone
Metyrapon
Metroprione
Metyrapone
2-Methyl-1,2-di-3-pyridyl-1-propanone
CAS号
54-36-4
EC号
200-206-2
MDL号
MFCD00006397
Beilstein号
163023
PubChem SID
46504862
160964347
24888424
PubChem CID
4174
CHEBI ID
44241
ATC码
V04CD01
CHEMBL
934
Chemspider ID
4030
DrugBank ID
DB01011
KEGG ID
D00410
美国药典/FDA物质标识码
ZS9KD92H6V
维基百科标题
Metyrapone

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) 1.9471339  LogD (pH = 7.4) 2.0277522 
Log P 2.028889  摩尔折射率 65.9444 cm3
极化性 25.544344 Å3 极化表面积 42.85 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 2.09  LOG S -2.72 
溶解度 4.27e-01 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
DMSO: >20 mg/mL expand 查看数据来源
H2O: <2 mg/mL expand 查看数据来源
Sparingly soluble expand 查看数据来源
外观
solid expand 查看数据来源
熔点
52-55 °C(lit.) expand 查看数据来源
闪点
>110 °C expand 查看数据来源
>230 °F expand 查看数据来源
疏水性(logP)
1.8 expand 查看数据来源
RTECS编号
UC3050000 expand 查看数据来源
欧盟危险性物质标志
有害性(Harmful) 有害性(Harmful) (Xn) expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
危险公开号
22-36/37/38 expand 查看数据来源
安全公开号
26 expand 查看数据来源
GHS危险品标识
GHS07 expand 查看数据来源
GHS警示词
Warning expand 查看数据来源
GHS危险声明
H302-H315-H319-H335 expand 查看数据来源
GHS警示性声明
P261-P305 + P351 + P338 expand 查看数据来源
个人保护装置
dust mask type N95 (US), Eyeshields, Gloves expand 查看数据来源
保存温度
room temp expand 查看数据来源
给药途径
Oral expand 查看数据来源
半衰期
1.9 ±0.7 hours. expand 查看数据来源
妊娠期药物分类
C US expand 查看数据来源
纯度
≥98% (HPLC) expand 查看数据来源
95+% expand 查看数据来源
96% expand 查看数据来源
Empirical Formula (Hill Notation)
C14H14N2O expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich
DrugBank -  DB01011 external link
Item Information
Drug Groups approved
Description An inhibitor of the enzyme steroid 11-beta-monooxygenase. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of cushing syndrome. [PubChem]
Indication Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function. Occasionally used in Cushing's syndrome.
Pharmacology Metopirone is an inhibitor of endogenous adrenal corticosteroid synthesis.
Toxicity Oral LD50 in rats is 521 mg/kg. One case has been recorded in which a 6-year-old girl died after two doses of Metopirone, 2 g. Symptoms of overdose include cardiac arrhythmias, hypotension, dehydration, anxiety, confusion, weakness, impairment of consciousness, nausea, vomiting, epigastric pain, and diarrhea.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic. The major biotransformation is reduction of the ketone to metyrapol, an active alcohol metabolite. Metyrapone and metyrapol are both conjugated with glucuronide.
Absorption Absorbed rapidly and well when administered orally. Peak plasma concentrations are usually reached 1 hour after administration.
Half Life 1.9 ±0.7 hours.
Elimination After administration of 4.5 g metyrapone (750 mg every 4 hours), an average of 5.3% of the dose was excreted in the urine in the form of metyrapone (9.2% free and 90.8% as glucuronide) and 38.5% in the form of metyrapol (8.1% free and 91.9% as glucuronide) within 72 hours after the first dose was given.
External Links
Wikipedia
RxList
Drugs.com
Sigma Aldrich -  M2696 external link
Biochem/physiol Actions
Metyrapone is a glucocorticoid synthesis inhibitor; a standard in assessing adrenal gland function especially in response to stress, as well as pituitary gland function. In addition to acting as a glucocorticoid synthesis inhibitor, Metyrapone also inhibits cytochrome P450-mediated prostaglandin ω/ω-1 hydroxylase activity and impairs learning and memory. Data shows results in activation of the sleep EEG and a robust decrease in quantitative delta sleep.
Sigma Aldrich -  856525 external link
包装
1 g in glass bottle
250 mg in glass bottle

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle